Skip NavigationSkip to Content

Fez1/Lzts1 alterations in gastric carcinoma

  1. Author:
    Vecchione, A.
    Ishii, H.
    Shiao, Y. H.
    Trapasso, F.
    Rugge, M.
    Tamburrino, J. F.
    Murakumo, Y.
    Alder, H.
    Croce, C. M.
    Baffa, R.
  2. Author Address

    Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, 1015 Walnut St, Suite 1102A, Philadelphia, PA 19107 USA. Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA. NCI, Frederick Canc Res & Dev Ctr, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA. Univ Padua, Dept Pathol, I-35126 Padua, Italy.
    1. Year: 2001
  1. Journal: Clinical Cancer Research
    1. 7
    2. 6
    3. Pages: 1546-1552
  2. Type of Article: Article
  1. Abstract:

    Purpose: Loss of heterozygosity (LOH) involving the short arm of chromosome 8 (8p) is a common feature of the malignant progression of human tumors, including gastric cancer, We have cloned and mapped a candidate tumor suppressor gene, FEZ1/LZTS1, to 8p22, Here we have analyzed whether FEZ1/LZTS1 alterations play a role in the development and progression of gastric carcinoma. Experimental Design: We examined Fez1/LZTS1 expression in 8 gastric carcinoma cell lines by Western blot, and in 88 primary gastric carcinomas by immunohistochemistry. Twenty-six of these 88 primary gastric carcinomas were also microdissected and tested for LOH at the FEZ1/LZTS1 locus and for mutation of the FEZI/LZTSI gene. Furthermore, we studied the FEZ1/LZTS1 gene regulation and transcriptional control and the methylation status of the 5' region of the gem in ah 8 gastric carcinoma cell lines. Results: Fez1/Lzts1 protein was barely detectable in all of the gastric cancer cell lines tested and was absent or significantly reduced in 39 of the 88 (44.3%) gastric tarcinomas analyzed by immunohistochemistry,,vith a significant correlation (P < 0.001) to diffuse histotype, DNA allelotyping analysis showed allelic loss in 3 of 17 (18%) and microsatellite instability in 4 of 17 (23.5%) cases informative for D8S261 at the FEZ1/LZTS1 locus. When we compared the presence of LOH with Fez1/Lzts1 expression, we found loss of protein expression in all three of the tumors with allelic imbalance at D8S261, A missense mutation was detected in one case that did not express Fez1/Lzts1, Hypermethylation of the CpG island flanking the Fez1/Lzts1 promoter was evident in six of the eight tell lines examined as well as in the normal control. Conclusions: Our findings support FEZI/LZTSI as a candidate tumor suppressor gene at gp in a subtype of gastric cancer and suggest that its inactivation is attributable to several factors including genomic deletion and methylation.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel